Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

ClinicalTrials.gov ID: NCT01302587

Public ClinicalTrials.gov record NCT01302587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open Label, Assessment of [an Albuterol] Hydrofluoroalkane (HFA) Metered Dose Inhaler MDI Integrated Dose Counter

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is evaluating the effectiveness of a dose counter for an inhaler device used to deliver medication to people diagnosed with asthma or COPD.

Study identification

NCT ID
NCT01302587
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
306 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jun 2011 (Actual)
Last update posted
Jun 22, 2012

2011

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Teva Clinical Study Site Glendale Arizona — —
Teva Clinical Study Site 10100 Mission Viejo California — —
Teva Clinical Study Site 10093 Orange California — —
Teva Clinical Study Site 10089 San Diego California — —
Teva Clinical Study Site 10098 Wheat Ridge Colorado — —
Teva Clinical Study Site Miami Florida — —
Teva Clinical Study Site 10082 Ormond Beach Florida — —
Teva Clinical Study Site Tamarac Florida — —
Teva Clinical Study Site 10090 Indianapolis Indiana — —
Teva Clinical Study Site 10097 Overland Park Kansas — —
Teva Clinical Study Site 10087 Wichita Kansas — —
Teva Clinical Study Site Fall River Massachusetts — —
Teva Clinical Study Site 10094 North Dartmouth Massachusetts — —
Teva Clinical Study Site 10086 Minneapolis Minnesota — —
Teva Clinical Study Site 10083 High Point North Carolina — —
Teva Clinical Study Site 10092 Raleigh North Carolina — —
Teva Clinical Study Site 10085 Canton Ohio — —
Teva Clinical Study Site 10080 Tulsa Oklahoma — —
Teva Clinical Study Site 10088 Eugene Oregon — —
Teva Clinical Study Site 10095 Portland Oregon — —
Teva Clinical Study Site 10081 Greenville South Carolina — —
Teva Clinical Study Site 10084 Spartanburg South Carolina — —
Teva Clinical Study Site Dallas Texas — —
Teva Clinical Study Site 10091 New Braunfels Texas — —
Teva Clinical Study Site 10099 Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01302587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01302587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →